Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Blind Dose-Ranging Pharmacodynamic Study of Auxora for the Treatment of Patients With Critical COVID-19 Pneumonia

NCT04661540 is registered in ClinicalTrials.gov with CalciMedica, Inc. as lead sponsor.

NCT NCT04661540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04661540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Blind Dose-Ranging Pharmacodynamic Study of Auxora for the Treatment of Patients With Critical COVID-19 Pneumonia
Lead sponsor
CalciMedica, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
March 2, 2021
Completion date
December 21, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia